Hereditary breast cancer and ovarian cancer

Standard

Hereditary breast cancer and ovarian cancer : Clinical course and treatment. / Semiglazov, V. V.; Protasova, A. E.; Kalikeev, G. K.

In: Opuholi Zenskoj Reproduktivnoj Sistemy, Vol. 16, No. 4, 2020, p. 54-65.

Research output: Contribution to journal › Article › peer-review

Author

Semiglazov, V. V. ; Protasova, A. E. ; Kalikeev, G. K. / Hereditary breast cancer and ovarian cancer : Clinical course and treatment. In: Opuholi Zenskoj Reproduktivnoj Sistemy. 2020 ; Vol. 16, No. 4. pp. 54-65.

BibTeX

@article{fb206b3394634af28a0cbffb59cd2601,

title = "Hereditary breast cancer and ovarian cancer: Clinical course and treatment",

abstract = "This article analyzes current problems associated with surgical and systemic treatment for hereditary breast and ovarian cancers (including those associated with BRCA1/2 gene mutations). We discuss the issues related to clinical course of multiple primary tumors and their sensitivity to cytostatic and targeted therapy.",

keywords = "BRCA1, BRCA2, Breast cancer, CHEK2, Multiple primary tumors, Ovarian cancer, PARP inhibitors",

author = "Semiglazov, {V. V.} and Protasova, {A. E.} and Kalikeev, {G. K.}",

year = "2020",

doi = "10.17650/1994-4098-2020-16-4-54-65",

language = "English",

volume = "16",

pages = "54--65",

journal = "Opuholi Zenskoj Reproduktivnoj Sistemy",

issn = "1994-4098",

publisher = "Издательский дом {"}АБВ-пресс{"} ",

number = "4",

}

RIS

TY - JOUR

T1 - Hereditary breast cancer and ovarian cancer

T2 - Clinical course and treatment

AU - Semiglazov, V. V.

AU - Protasova, A. E.

AU - Kalikeev, G. K.

PY - 2020

Y1 - 2020

N2 - This article analyzes current problems associated with surgical and systemic treatment for hereditary breast and ovarian cancers (including those associated with BRCA1/2 gene mutations). We discuss the issues related to clinical course of multiple primary tumors and their sensitivity to cytostatic and targeted therapy.

AB - This article analyzes current problems associated with surgical and systemic treatment for hereditary breast and ovarian cancers (including those associated with BRCA1/2 gene mutations). We discuss the issues related to clinical course of multiple primary tumors and their sensitivity to cytostatic and targeted therapy.

KW - BRCA1

KW - BRCA2

KW - Breast cancer

KW - CHEK2

KW - Multiple primary tumors

KW - Ovarian cancer

KW - PARP inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85108941045&partnerID=8YFLogxK

U2 - 10.17650/1994-4098-2020-16-4-54-65

DO - 10.17650/1994-4098-2020-16-4-54-65

M3 - Article

AN - SCOPUS:85108941045

VL - 16

SP - 54

EP - 65

JO - Opuholi Zenskoj Reproduktivnoj Sistemy

JF - Opuholi Zenskoj Reproduktivnoj Sistemy

SN - 1994-4098

IS - 4

ER -

ID: 88554169